Download PDF

Other users also viewed these articles

Prevalence of metabolic associated fatty liver disease (MAFLD) in patients with gallstone disease. Study on a cohort of cases in South-Southeastern Mexico F. Roesch-Dietlen; A.G. Pérez-Morales; P. Grube-Pagola; M. González-Santes; F. Díaz-Roesch; A. Triana-Romero; L. Roesch-Ramos; J.M. Remes-Troche; M. Cruz-Aguilar;
Rev Gastroenterol Mex. 2023;88:225-31
Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU J.K. Yamamoto-Furusho; D. Andrade; J. Barahona; S. Bautista; F. Bosques-Padilla; J. de Paula; M.T. Galiano; B. Iade; F. Juliao-Baños; G. Otoya; F. Steinwurz; E. Torres; G. Veitia; M. Barreiro-de Acosta;
Rev Gastroenterol Mex. 2022;87:89-102
Inflammatory bowel disease in Mexico: Epidemiology, burden of disease, and treatment trends J.K. Yamamoto-Furusho; F.J. Bosques-Padilla; L. Charúa-Guindic; T. Cortés-Espinosa; R.M. Miranda-Cordero; A. Saez; Y. Ledesma-Osorio;
Rev Gastroenterol Mex. 2020;85:246-56